- Home
- KRMD vs IKT Comparison
KRMD vs IKT Comparison
Compare KRMD & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRMD | IKT |
|---|---|---|
| Founded | 1980 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.0M | 201.3M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | KRMD | IKT |
|---|---|---|
| Price | $4.50 | $2.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $6.00 | $5.50 |
| AVG Volume (30 Days) | 152.8K | ★ 2.1M |
| Earning Date | 04-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 56.67 | ★ 67.51 |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $33,646,463.00 | N/A |
| Revenue This Year | $24.39 | N/A |
| Revenue Next Year | $18.14 | N/A |
| P/E Ratio | $90.20 | ★ N/A |
| Revenue Growth | ★ 17.98 | N/A |
| 52 Week Low | $1.87 | $1.33 |
| 52 Week High | $6.61 | $2.58 |
Technical Indicators
Market Signals| Indicator | KRMD | IKT |
|---|---|---|
| Relative Strength Index (RSI) | 36.84 | 60.47 |
| Support Level | $3.80 | $1.45 |
| Resistance Level | $5.12 | $2.14 |
| Average True Range (ATR) | 0.22 | 0.15 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 8.82 | 53.64 |
Price Performance
Historical ComparisonAbout KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.